Esbriet is a medication used to treat idiopathic pulmonary fibrosis (IPF), a progressive and life-threatening lung condition. It is one of the few drugs approved by the U.S. Food and Drug Administration (FDA) for this purpose. So, who makes Esbriet? This article will provide an overview of the drug’s manufacturer and its history of innovation in the field of IPF treatment. We’ll explore how Esbriet came to be, its efficacy, and how it is helping to improve the quality of life for IPF patients around the world.
Esbriet is made by InterMune, a biotechnology company located in Brisbane, California. InterMune has been developing and marketing treatments for pulmonary diseases since 1998.
What is Esbriet?
Esbriet is a prescription medicine used to treat a group of lung diseases known as idiopathic pulmonary fibrosis (IPF). IPF is a type of lung disease that causes scarring in the lungs, making it hard to breathe. Esbriet helps slow down the progression of the disease and can help improve lung capacity.
Who Makes Esbriet?
Esbriet is made by InterMune, a biotechnology company based in the United States. The company has been researching treatments for a variety of respiratory diseases since 1996.
Esbriet is the first drug to be approved by the FDA for the treatment of IPF. InterMune is currently researching other treatments for IPF and other respiratory diseases.
Esbriet is available in the United States and in more than 50 other countries around the world. It is currently only available as a brand-name drug, meaning that it is not available in generic form.
What is the Dosage for Esbriet?
Esbriet is taken in two forms: a pill or a powder. The recommended dosage for adults is two 250-mg pills taken twice daily, or one 250-mg packet of powder taken twice daily.
Are There Side Effects?
Esbriet can cause side effects, some of which can be serious. Common side effects include nausea, diarrhea, and rash. Less common side effects include liver problems and changes in vision. People taking Esbriet should talk to their doctor about any side effects they may experience.
What Precautions Should I Take?
Esbriet may interact with other medications, so it is important to tell your doctor about all the medications you are taking. People taking Esbriet should avoid alcohol and should not drive or operate heavy machinery until they know how the medication affects them.
It is also important to tell your doctor if you have any liver problems, as this can make Esbriet less effective. Women who are pregnant or breastfeeding should talk to their doctor before taking Esbriet.
Top 6 Frequently Asked Questions
Who Makes Esbriet?
Answer: Esbriet is manufactured by InterMune, Inc., a biopharmaceutical company headquartered in Brisbane, California. InterMune is focused on the research, development and commercialization of innovative therapies in pulmonology, hepatology and orphan fibrotic diseases. Esbriet is the company’s only FDA-approved product for the treatment of idiopathic pulmonary fibrosis (IPF).
How Does Esbriet Work?
Answer: Esbriet works by inhibiting the activity of an enzyme called phosphodiesterase-4 (PDE4), which is involved in the production of pro-inflammatory molecules in the lungs. By inhibiting PDE4, Esbriet helps to reduce inflammation and slow the progression of IPF. Esbriet is taken orally once daily and is available in capsules and a granule formulation.
Who Can Take Esbriet?
Answer: Esbriet is approved for use in adults with mild to moderate IPF. It is not recommended for people with severe IPF or people with certain other medical conditions. Patients should talk to their doctor to determine if Esbriet is right for them.
What are the Side Effects of Esbriet?
Answer: The most common side effects of Esbriet include nausea, diarrhea, upper respiratory tract infection, and abdominal pain. Less common side effects may include rash, headache, dizziness, and muscle pain. Patients should talk to their doctor about any side effects they experience while taking Esbriet.
What are the Warnings and Precautions for Esbriet?
Answer: Esbriet is not recommended for people with severe IPF or people with certain other medical conditions. Patients should also talk to their doctor before taking Esbriet if they have a history of liver disease or are taking any other medications. Some of these medications may interact with Esbriet and increase the risk of side effects.
What is the Cost of Esbriet?
Answer: The cost of Esbriet varies depending on the pharmacy and the dosage being prescribed. Patients should contact their insurance provider to determine if Esbriet is covered under their plan. Patients may also be eligible for patient assistance programs to help with the cost.
Pirfenidone and Nintedanib: Tips for Treating Patients with Idiopathic Pulmonary Fibrosis
Esbriet is a revolutionary medication prescribed to help slow the progression of idiopathic pulmonary fibrosis (IPF), a progressive and ultimately fatal lung disease. It is a breakthrough drug developed and manufactured by InterMune, Inc., a biotech company dedicated to providing patients with innovative treatments and therapies. By slowing the progression of IPF, Esbriet provides a much-needed ray of hope to the millions of people living with this serious and ultimately fatal condition. Thanks to InterMune’s commitment to developing innovative treatments and therapies, people living with IPF can look forward to a brighter future.